DZ Bank Put 25 1SXP/ DE000DJ52128 /
2024-05-27 8:09:18 AM | Chg.- | Bid10:00:36 PM | Ask10:00:36 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.037EUR | - | - Bid Size: - |
- Ask Size: - |
SCHOTT PHARMA INH O.... | 25.00 - | 2024-06-21 | Put |
GlobeNewswire
11:00 PM
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
11:00 PM
Goodness Growth Holdings Announces Voting Results of Annual General and Special Meeting of Sharehold...
GlobeNewswire
10:50 PM
argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropat...
GlobeNewswire
10:45 PM
ANEW MEDICAL, INC. and REDWOOD ACQUISITION CORP. ANNOUNCE CLOSING OF THEIR BUSINESS COMBINATION
Newsfile Corp
10:43 PM
Heliostar Announces Initial Closing of $4.5 Million Offering with Lead Order from Eric Sprott
GlobeNewswire
10:15 PM
Thunder Power Holdings, Inc. Announces Consummation of Business Combination and Commencement of Trad...
GlobeNewswire
10:15 PM
Norwood Financial Corp Announces Appointment of John M. McCaffery as Executive Vice President and Ch...
GlobeNewswire
10:06 PM
Sunrise New Energy’s Lithium-Ion Battery Patent Granted Key Funding in Guizhou Province
GlobeNewswire
10:05 PM
Blackwells Releases Letter to Fellow Shareholders Highlighting Ongoing Corporate Piracy Being Carrie...
GlobeNewswire
10:05 PM
Alpine Income Property Trust Announces Year-To-Date 2024 Transaction Activity
GlobeNewswire
10:05 PM
Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 20...
GlobeNewswire
10:04 PM
On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
GlobeNewswire
10:01 PM
Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under ...
GlobeNewswire
10:00 PM
Inteleos’ Point-of-Care Ultrasound Certification Academy Launches Comprehensive Maternal Fetal Healt...
GlobeNewswire
10:00 PM
HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
GlobeNewswire
10:00 PM
Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024